Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis

Alzheimer’s disease (AD) is a complex neurodegenerative disease that requires extremely specific biomarkers for its diagnosis. For current diagnostics capable of identifying AD, the development and validation of early stage biomarkers is a top research priority. Body-fluid biomarkers might closely r...

Full description

Bibliographic Details
Main Authors: Thuy Trang Nguyen, Qui Thanh Hoai Ta, Thi Kim Oanh Nguyen, Thi Thuy Dung Nguyen, Van Giau Vo
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/10/5/326
_version_ 1827716489689432064
author Thuy Trang Nguyen
Qui Thanh Hoai Ta
Thi Kim Oanh Nguyen
Thi Thuy Dung Nguyen
Van Giau Vo
author_facet Thuy Trang Nguyen
Qui Thanh Hoai Ta
Thi Kim Oanh Nguyen
Thi Thuy Dung Nguyen
Van Giau Vo
author_sort Thuy Trang Nguyen
collection DOAJ
description Alzheimer’s disease (AD) is a complex neurodegenerative disease that requires extremely specific biomarkers for its diagnosis. For current diagnostics capable of identifying AD, the development and validation of early stage biomarkers is a top research priority. Body-fluid biomarkers might closely reflect synaptic dysfunction in the brain and, thereby, could contribute to improving diagnostic accuracy and monitoring disease progression, and serve as markers for assessing the response to disease-modifying therapies at early onset. Here, we highlight current advances in the research on the capabilities of body-fluid biomarkers and their role in AD pathology. Then, we describe and discuss current applications of the potential biomarkers in clinical diagnostics in AD.
first_indexed 2024-03-10T19:42:25Z
format Article
id doaj.art-038fdc4f77f34faf8584031efef2e1ad
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T19:42:25Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-038fdc4f77f34faf8584031efef2e1ad2023-11-20T01:07:35ZengMDPI AGDiagnostics2075-44182020-05-0110532610.3390/diagnostics10050326Role of Body-Fluid Biomarkers in Alzheimer’s Disease DiagnosisThuy Trang Nguyen0Qui Thanh Hoai Ta1Thi Kim Oanh Nguyen2Thi Thuy Dung Nguyen3Van Giau Vo4Faculty of Pharmacy, Ho Chi Minh City University of Technology (HUTECH), Ho Chi Minh City 700000, VietnamInstitute of Research and Development, Duy Tan University, Danang 550000, VietnamFaculty of Food Science and Technology, Ho Chi Minh City University of Food Industry, Ho Chi Minh City 700000, VietnamFaculty of Environmental and Food Engineering, Nguyen Tat Thanh University, Ho Chi Minh City 70000, VietnamDepartment of Industrial and Environmental Engineering, Graduate School of Environment, Gachon University, 1342 Sungnam-daero, Sujung-gu, Seongnam-si, Gyeonggi-do 461-701, KoreaAlzheimer’s disease (AD) is a complex neurodegenerative disease that requires extremely specific biomarkers for its diagnosis. For current diagnostics capable of identifying AD, the development and validation of early stage biomarkers is a top research priority. Body-fluid biomarkers might closely reflect synaptic dysfunction in the brain and, thereby, could contribute to improving diagnostic accuracy and monitoring disease progression, and serve as markers for assessing the response to disease-modifying therapies at early onset. Here, we highlight current advances in the research on the capabilities of body-fluid biomarkers and their role in AD pathology. Then, we describe and discuss current applications of the potential biomarkers in clinical diagnostics in AD.https://www.mdpi.com/2075-4418/10/5/326Alzheimer’s diseasebiomarkersdiagnosticsAβCSFtau
spellingShingle Thuy Trang Nguyen
Qui Thanh Hoai Ta
Thi Kim Oanh Nguyen
Thi Thuy Dung Nguyen
Van Giau Vo
Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
Diagnostics
Alzheimer’s disease
biomarkers
diagnostics

CSF
tau
title Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
title_full Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
title_fullStr Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
title_full_unstemmed Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
title_short Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
title_sort role of body fluid biomarkers in alzheimer s disease diagnosis
topic Alzheimer’s disease
biomarkers
diagnostics

CSF
tau
url https://www.mdpi.com/2075-4418/10/5/326
work_keys_str_mv AT thuytrangnguyen roleofbodyfluidbiomarkersinalzheimersdiseasediagnosis
AT quithanhhoaita roleofbodyfluidbiomarkersinalzheimersdiseasediagnosis
AT thikimoanhnguyen roleofbodyfluidbiomarkersinalzheimersdiseasediagnosis
AT thithuydungnguyen roleofbodyfluidbiomarkersinalzheimersdiseasediagnosis
AT vangiauvo roleofbodyfluidbiomarkersinalzheimersdiseasediagnosis